Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed
ContributorsButler, Mark S ; Gigante, Valeria; Sati, Hatim; Pastore, Pauline; Al-Sulaiman, Laila; Rex, John H; Fernandes, Prabhavathi; Arias, Cesar A; Paul, Mical; Thwaites, Guy E; Czaplewski, Lloyd; Alm, Richard A ; Lienhardt, Christian; Spigelman, Melvin; Silver, Lynn L; Ohmagari, Norio; Kozlov, Roman; Harbarth, Stéphan Juergen ; Beyer, Peter
Published inAntimicrobial agents and chemotherapy, vol. 66, no. 3, e0199121
Publication date2022-03-15
First online date2022-01-10
Abstract
Keywords
- Clostridioides difficile
- WHO priority pathogens
- Antibacterial pipeline
- Antibiotic
- Clinical trials
- Mycobacteria
- Nontraditional
- Traditional
- Tuberculosis.
Affiliation entities
Research groups
Funding
- World Health Organization - [001]
Citation (ISO format)
BUTLER, Mark S et al. Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed. In: Antimicrobial agents and chemotherapy, 2022, vol. 66, n° 3, p. e0199121. doi: 10.1128/AAC.01991-21
Secondary files (1)
Identifiers
- PID : unige:162607
- DOI : 10.1128/AAC.01991-21
- PMID : 35007139
ISSN of the journal0066-4804